Anuradha Chakravarthy, MD | Authors

Berta de Leon

6320 Elm Ct

Bellaire

77087-2544

Articles

Weekly Irinotecan and Concurrent Radiation Therapy for Stage III Unresectable NSCLC

July 02, 2000

In preclinical studies, the topoisomerase I inhibitor irinotecan (Camptosar, CPT-11) has demonstrated activity as a radiosensitizer, probably due to its ability to inhibit potentially lethal radiation damage repair. We conducted a

The Role of Radiation, With or Without Chemotherapy, in the Management of NSCLC

October 01, 1999

Lung cancer is the leading cause of cancer death in the United States. Surgery is the treatment of choice for early stage patients. Despite radical surgery, patients with early stage lung cancer remain at risk for recurrence. The